B. Harrow

732 total citations
42 papers, 454 citations indexed

About

B. Harrow is a scholar working on Pulmonary and Respiratory Medicine, Economics and Econometrics and General Health Professions. According to data from OpenAlex, B. Harrow has authored 42 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Economics and Econometrics and 8 papers in General Health Professions. Recurrent topics in B. Harrow's work include Allergic Rhinitis and Sensitization (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Geriatric Care and Nursing Homes (5 papers). B. Harrow is often cited by papers focused on Allergic Rhinitis and Sensitization (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Geriatric Care and Nursing Homes (5 papers). B. Harrow collaborates with scholars based in United States, France and United Kingdom. B. Harrow's co-authors include Sharon L. Tennstedt, J. B. McKinlay, Janet B. Mitchell, James Pike, Mark Small, David Price, Victoria Higgins, Sybil L. Crawford, Linda Kasten and Mark A. Moskowitz and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Health Affairs.

In The Last Decade

B. Harrow

40 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Harrow United States 11 166 80 76 74 70 42 454
Alessandro Gonçalves Campolina Brazil 15 190 1.1× 51 0.6× 50 0.7× 134 1.8× 34 0.5× 44 568
Lih‐Wen Mau United States 14 154 0.9× 43 0.5× 50 0.7× 111 1.5× 33 0.5× 47 731
Nina S. Wampler United States 14 186 1.1× 47 0.6× 83 1.1× 32 0.4× 77 1.1× 18 843
Irena Stijacic‐Cenzer United States 10 235 1.4× 33 0.4× 124 1.6× 93 1.3× 59 0.8× 11 610
Lien Nguyen Finland 15 116 0.7× 82 1.0× 33 0.4× 80 1.1× 29 0.4× 37 588
Judy Ng United States 18 284 1.7× 31 0.4× 38 0.5× 189 2.6× 48 0.7× 39 653
Erin Duffy United States 14 167 1.0× 32 0.4× 24 0.3× 110 1.5× 72 1.0× 51 591
Margalit Goldfracht Israel 15 156 0.9× 34 0.4× 26 0.3× 49 0.7× 21 0.3× 39 818
Sandra van Dijk Netherlands 15 128 0.8× 22 0.3× 102 1.3× 43 0.6× 58 0.8× 42 686
Cori Blauer‐Peterson United States 13 87 0.5× 61 0.8× 36 0.5× 49 0.7× 99 1.4× 33 651

Countries citing papers authored by B. Harrow

Since Specialization
Citations

This map shows the geographic impact of B. Harrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Harrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Harrow more than expected).

Fields of papers citing papers by B. Harrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Harrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Harrow. The network helps show where B. Harrow may publish in the future.

Co-authorship network of co-authors of B. Harrow

This figure shows the co-authorship network connecting the top 25 collaborators of B. Harrow. A scholar is included among the top collaborators of B. Harrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Harrow. B. Harrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tap, William D., Vivek A. Bhadri, Silvia Stacchiotti, et al.. (2024). Efficacy, safety, and patient-reported outcomes of vimseltinib in patients with tenosynovial giant cell tumor: Results from the phase 3 MOTION trial.. Journal of Clinical Oncology. 42(16_suppl). 11500–11500. 2 indexed citations
2.
Brown, Janet E., et al.. (2021). 680P Cabozantinib and axitinib after VEGF therapy in patients with aRCC: A retrospective cohort study. Annals of Oncology. 32. S701–S701. 1 indexed citations
3.
Marteau, Florence, B. Harrow, Christine McCarthy, et al.. (2021). Cabozantinib versus other TKIs after CPI treatment in the real-world management of patients with metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 39(6_suppl). 293–293. 6 indexed citations
4.
5.
Harrow, B., et al.. (2019). PCN151 DO GASTROINTESTINAL SYMPTOMS DELAY THE DIAGNOSIS OF OVARIAN CANCER?. Value in Health. 22. S84–S84. 1 indexed citations
6.
7.
Harrow, B., et al.. (2015). Health-care costs of asthma are lower using mp29-02* vs. Sequential sprays for allergic rhinitis. Value in Health. 18(3). A172–A173. 1 indexed citations
8.
Price, David, B. Harrow, Mark Small, James Pike, & Victoria Higgins. (2015). Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians. World Allergy Organization Journal. 8(1). 26–26. 53 indexed citations
9.
10.
Harrow, B., Christoph R. Becker, & Ami Buikema. (2011). PRS23 High Cost Cystic Fibrosis Patients as Identified in a Us Claims Database: A Closer Look at the Tail. Value in Health. 14(7). A491–A491. 1 indexed citations
11.
Harrow, B., et al.. (2011). Health Utilities Associated with Hemoglobin Levels and Blood Loss in Postmenopausal Women: The Women's Health Initiative. Value in Health. 14(4). 555–563. 6 indexed citations
12.
Becker, Christoph R., et al.. (2011). PRS18 Economic Burden of Cystic Fibrosis in the US: Costs of Care By Disease Severity and Age. Value in Health. 14(7). A490–A490. 4 indexed citations
13.
Schutt, Russell K., et al.. (2010). Case Manager Satisfaction in Public Health. Professional Case Management. 15(3). 124–134. 3 indexed citations
14.
Harrow, B., Christopher P. Tompkins, Paul D. Mitchell, et al.. (2006). The Impact of Publicly Funded Managed Care on Adolescent Substance Abuse Treatment Outcomes. The American Journal of Drug and Alcohol Abuse. 32(3). 379–398. 3 indexed citations
15.
McKinlay, John B., Risa B. Burns, Richard Durante, et al.. (1997). Patient, physician and presentational influences on clinical decision making for breast cancer: results from a factorial experiment*. Journal of Evaluation in Clinical Practice. 3(1). 23–57. 59 indexed citations
16.
Harrow, B., Thomas M. Lasater, & Kim M. Gans. (1996). A Strategy for Accurate Collection of Incremental Cost Data for Cost-Effectiveness Analyses in Field Trials. Evaluation Review. 20(3). 275–290. 5 indexed citations
17.
Harrow, B., Sharon L. Tennstedt, & J. B. McKinlay. (1995). How Costly Is It To Care for Disabled Elders in a Community Setting?. The Gerontologist. 35(6). 803–813. 59 indexed citations
18.
Mitchell, Janet B. & B. Harrow. (1994). Costs and outcomes of inpatient versus outpatient hernia repair. Health Policy. 28(2). 143–152. 33 indexed citations
19.
Vertrees, James C., et al.. (1990). The case mix of ambulatory surgery as measured by ambulatory visit groups. Journal of Ambulatory Care Management. 13(1). 33–45. 5 indexed citations
20.
Rosenbach, Margo, et al.. (1988). Physician participation in alternative health plans.. PubMed. 9(4). 63–79. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandro Gonçalves Campolina Breakdown of academic impact, for papers by Lih‐Wen Mau Breakdown of academic impact, for papers by Nina S. Wampler Breakdown of academic impact, for papers by Irena Stijacic‐Cenzer Breakdown of academic impact, for papers by Lien Nguyen Breakdown of academic impact, for papers by Judy Ng Breakdown of academic impact, for papers by Erin Duffy Breakdown of academic impact, for papers by Margalit Goldfracht Breakdown of academic impact, for papers by Sandra van Dijk Breakdown of academic impact, for papers by Cori Blauer‐Peterson
Rankless by CCL
2026